The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies☆
- 31 August 2004
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 22 (4) , 362-368
- https://doi.org/10.1016/j.urolonc.2004.04.009
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Estimating the Impact of New Clinical Trial Proven Cancer Therapy and Cancer Chemoprevention on Population Mortality: The Karnofsky Memorial LectureJournal of Clinical Oncology, 2003
- The Influence of Finasteride on the Development of Prostate CancerNew England Journal of Medicine, 2003
- Prostate cancer prevention trial yields positive results, but with a few cautions.JNCI Journal of the National Cancer Institute, 2003
- Estimates of the Number of U.S. Women Who Could Benefit From Tamoxifen for Breast Cancer ChemopreventionJNCI Journal of the National Cancer Institute, 2003
- Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast CancerJNCI Journal of the National Cancer Institute, 1999
- National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial: A Reflective CommentaryJournal of Clinical Oncology, 1999
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Pathological changes in benign and malignant prostatic tissue following androgen deprivation therapyUrology, 1997
- Value Judgment in the Oregon Medicaid ExperimentMedical Care, 1994
- Methods for assessing relative importance in preference based outcome measuresQuality of Life Research, 1993